PLACIDA is a combination of Flupenthixol and Melitracen which belongs to the group of medicines called Antipsychotics and Tricyclic antidepressants respectively. It is used in the treatment of neurasthenia (condition that causes physical and mental exhaustion usually with accompanying symptoms (such as headache and irritability)), psychogenic depression, depressive neuroses, masked depression, menopausal depression, dysphoria (profound state of unease or dissatisfaction) and depression in alcoholics and drug-addicts, psychosomatic affections that is accompanied by anxiety and apathy.
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest that affects a person how he feels, thinks and behaves leading to a variety of emotional and physical problems associated with symptoms such as changes in sleep, appetite and daily behaviour. Anxiety is a feeling of fear, dread, and uneasiness which is generally characterized by symptoms such as fast heart rate, rapid breathing, sweating and tiredness.
Avoid taking PLACIDA if you have mania or heart diseases such as circulatory collapse, depressed level of consciousness, blood disorders, hereditary problems of galactose (sugar) intolerance. Before taking PLACIDA, inform your doctor if you have convulsions, organic brain syndrome, history of suicide related events, diabetes, planned surgeries, reduced liver or kidney function.
PLACIDA is not recommended for use in pregnant women unless clearly advised by the doctor and it should be used with caution in breastfeeding women as it can pass through breast milk. PLACIDA is not recommended for use in children and adolescents (below 18 years of age) and it should be used with caution in elderly patients (aged above 75 years).
The most common side effects of taking PLACIDA are sleeplessness, restlessness, agitation, dizziness, tremor (involuntary movement of muscles), dry mouth and constipation. Consult your doctor if any of the side effect gets worsen.